Equity Analysis

Company Profile

Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets

Company News

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

474.522963

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

73.75

100599.32

EPS(TTM)

Face Value()

Div & Yield %:

51.38

0.79

Back

P.M. Telelinnks standalone net profit declines 71.43% in the September 2023 quarter

Nov 10,2023

Net profit of P.M. Telelinnks declined 71.43% to Rs 0.02 crore in the quarter ended September 2023 as against Rs 0.07 crore during the previous quarter ended September 2022. Sales rose 58.18% to Rs 12.18 crore in the quarter ended September 2023 as against Rs 7.70 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	12.18	7.70	58
OPM %	0.25	1.17	-
PBDT	0.03	0.09	-67
PBT	0.03	0.09	-67
NP	0.02	0.07	-71